Clinical Trials Browser

Nasopharyngeal Carcinoma

Diffuse Intrinsic Pontine Glioma, Glioma

Colonic Neoplasms

Pathologic Complete Response, Rectal Neoplasms

Immune-Related Adverse Events

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Small Cell Lung Carcinoma

Solid Cancers

Carcinoma, Non-Small-Cell Lung

Neoplasm Metastasis, Neoplasms

Esophageal Neoplasms

Small Cell Lung Cancer Extensive Stage

Stomach Neoplasms

Triple Negative Breast Neoplasms

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial

Neoadjuvant Therapies

Colonic Neoplasms

Carcinoma, Hepatocellular

Advanced Solid Tumors

Biliary Tract Neoplasms

Lupus Erythematosus, Systemic, Myositis, Scleroderma, Systemic, Sjogren's Syndrome

Carcinoma, Hepatocellular

Locally Advanced Colorectal Carcinoma

Pancreatic Neoplasms

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

NSCLC Stage IV Without EGFR/ALK Mutation

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Locally Advanced Rectal Cancer (LARC)

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Leukemia, Myeloid, Acute

Stomach Neoplasms

Advanced Solid Tumor

Carcinoma, Hepatocellular, Liver Neoplasms

Small Cell Lung Carcinoma

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

Carcinoma, Hepatocellular

Advanced NSCLC

Advanced NSCLC

Advanced NSCLC

Advanced NSCLC

Clinical Trials

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

TRIUNITE-08

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

JACKPOT38

PRISM-TNBC

A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC

MINER

Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

iFOCUS

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

SKY

G/GEJ

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Lalo

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

MODIFI-CC

MODIFI-L

Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention

Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors

AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study

An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.

INTER-AUTENTIC

Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation

Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

TASK-01-RW

TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma

Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC

A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases

An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

STELLARIII

PROPHET

Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer

XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis

Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors

CCGLC-001

Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy

Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment